Fibroblast: A Novel Target for Autoimmune and Inflammatory Skin Diseases Therapeutics
Clinical Reviews in Allergy & Immunology · 2024
DOI: 10.1007/s12016-024-08997-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Reviews in Allergy & Immunology, 2024. Verfasst von Xiaoyun Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, Second Xiangya Hospital, Central South University, Changsha, 410011, China. Hauptthemen laut MEDLINE: Fibroblasts, Autoimmune Diseases, Skin Diseases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 174 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the National Key R&D Program of China, the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Fibroblasts are crucial components of the skin structure. They were traditionally believed to maintain the skin's structure by producing extracellular matrix and other elements. Recent research illuminated that fibroblasts can respond to external stimuli and exhibit diverse functions, such as the secretion of pro-inflammatory factors, adipogenesis, and antigen presentation, exhibiting remarkable heterogeneity and plasticity. This revelation positions fibroblasts as active contributors to the pathogenesis of skin diseases, challenging the traditional perspective that views fibroblasts solely as structural entities. Based on their diverse functions, fibroblasts can be categorized into six subtypes: pro-inflammatory fibroblasts, myofibroblasts, adipogenic fibroblasts, angiogenic fibroblasts, mesenchymal fibroblasts, and antigen-presenting fibroblasts. Cytokines, metabolism, and epigenetics regulate functional abnormalities in fibroblasts. The dynamic changes fibroblasts exhibit in different diseases and disease states warrant a comprehensive discussion. We focus on dermal fibroblasts' aberrant manifestations and pivotal roles in inflammatory and autoimmune skin diseases, including psoriasis, vitiligo, lupus erythematosus, scleroderma, and atopic dermatitis, and propose targeting aberrantly activated fibroblasts as a potential therapeutic strategy for inflammatory and autoimmune skin diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, Second Xiangya Hospital, Central South University, Changsha, 410011, China.
- Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, 210042, China. sujiejia@126.com.
- Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China. sujiejia@126.com.
- Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, Second Xiangya Hospital, Central South University, Changsha, 410011, China. zhaoming301@pumcderm.cams.cn.
- Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, 210042, China. zhaoming301@pumcderm.cams.cn.
- Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China. zhaoming301@pumcderm.cams.cn.
Förderung
- the National Natural Science Foundation of China
- the National Key R&D Program of China
- the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
- the CAMS Innovation Fund for Medical Sciences (CIFMS)
Zitieren
APA
Chen, X., Wu, Y., Jia, S., & Zhao, M. (2024). Fibroblast: A Novel Target for Autoimmune and Inflammatory Skin Diseases Therapeutics. Clinical Reviews in Allergy & Immunology. https://doi.org/10.1007/s12016-024-08997-1
Vancouver
Chen X, Wu Y, Jia S, Zhao M. Fibroblast: A Novel Target for Autoimmune and Inflammatory Skin Diseases Therapeutics. Clinical Reviews in Allergy & Immunology. 2024. doi:10.1007/s12016-024-08997-1
BibTeX
@article{Chen2024,
author = {Chen, Xiaoyun and Wu, Yutong and Jia, Sujie and Zhao, Ming},
title = {Fibroblast: A Novel Target for Autoimmune and Inflammatory Skin Diseases Therapeutics},
journal = {Clinical Reviews in Allergy & Immunology},
year = {2024},
doi = {10.1007/s12016-024-08997-1}
}
EUVIMED